As with other medicines in the incretin-based drug class, the most commonly reported side effects of retatrutide in clinical trials were gastrointestinal in nature (Jastreboff et al., 2023)
Phase 3 data will be required before any firm conclusions can be drawn
The Future of Peptide Nasal Delivery Emerging Research and Applications The field of peptide therapeutics continues evolving rapidly: Novel formulations : Enhanced bioavailability through improved delivery systems Combination products : Pre-mixed blends optimized for specific outcomes Smart delivery devices : Dose-tracking and timing optimization technology Expanded research : Growing clinical investigation into peptide applications Regulatory Landscape in 2026 The regulatory environment for peptides remains dynamic: FDA oversight of compounding practices International import/export regulations Quality standard evolution Professional practice guidelines Staying informed about regulatory changes ensures compliant, responsible use
These data suggest that Gcg expression and GLP-1 synthesis within the pancreas is necessary for the glucoregulatory role of DPP-4 inhibitors
Nitric oxide synthases: Regulation and function
Preston RA, Ledford M, Materson BJ, Baltodano NM, Memon A, Alonso A